» Articles » PMID: 16540761

Natural History of Nonalcoholic Steatohepatitis

Overview
Specialty Gastroenterology
Date 2006 Mar 17
PMID 16540761
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Nonalcoholic fatty liver disease (NAFLD) is being increasingly recognized as one of the most common chronic liver diseases. The natural history of this liver disease remains unclear due to its indolent nature, the paucity of prospective studies, and the lack of consensus regarding the various forms of this disorder. Based on retrospective studies, it appears that the histologic features of NAFLD may be important determinants of the clinical course of this disease; patients with nonalcoholic steatohepatitis (NASH) appear to have a higher likelihood of progression to cirrhosis. There is an increased risk of hepatocellular carcinoma and end-stage liver disease among patients with NASH-related cirrhosis and those with cryptogenic cirrhosis, which likely represents a late stage of NAFLD. Recurrence of NASH has been described among patients who have undergone liver transplantation for NASH-related end-stage liver disease.

Citing Articles

Association between paravertebral muscle radiological parameter alterations and non-alcoholic fatty liver disease.

Lin L, Chen M, Huang X, Song J, Ye X, Liu K Abdom Radiol (NY). 2024; 49(7):2250-2261.

PMID: 38801559 DOI: 10.1007/s00261-024-04352-2.


Non-alcoholic fatty liver disease fibrosis score is a useful index for predicting all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Whang J, Park P, Park Y, Huh J, Lee S Front Med (Lausanne). 2023; 10:1217937.

PMID: 37711740 PMC: 10497776. DOI: 10.3389/fmed.2023.1217937.


The role of bariatric surgery in liver transplantation: timing and type.

Safavi D, Creavin B, Gallagher T, Kelly M Langenbecks Arch Surg. 2022; 407(8):3249-3258.

PMID: 35851812 PMC: 9722877. DOI: 10.1007/s00423-022-02606-5.


Diagnosis of steatohepatitis and fibrosis in biopsy-proven nonalcoholic fatty liver diseases: including two-dimension real-time shear wave elastography and noninvasive fibrotic biomarker scores.

Zhou J, Yan F, Xu J, Lu Q, Zhu X, Gao B Quant Imaging Med Surg. 2022; 12(3):1800-1814.

PMID: 35284290 PMC: 8899947. DOI: 10.21037/qims-21-700.


Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.

Seo D, Suh Y, Cho Y, Ahn S, Seo S, Hong S Diabetes Metab J. 2022; 46(4):630-639.

PMID: 35081304 PMC: 9353562. DOI: 10.4093/dmj.2021.0130.